Belimumab-Rituximab Combo Reduces Lupus Treatment Failure
Summary
Stopping mycophenolate mofetil but continuing B cell-targeted therapy after induction leads to fewer disease-related treatment failures and renal flares, but larger studies are needed.
Description from Medscape.
Who is covering this
-
Belimumab-Rituximab Combo Reduces Lupus Treatment Failure
Stopping mycophenolate mofetil but continuing B cell-targeted therapy after induction leads to fewer disease-related treatment failures and renal flares, but larger studies are needed.
Comments
Comments need JavaScript.